Clayton joined the Microbiota Research and Therapeutics team in 2018. He assists in the GMP production of intestinal microbiota transplant therapeutics. In addition to the therapeutics program, he also conducts research with modified bile acids to ascertain their capacity to inhibit C. difficile spore germination in vivo.
Clayton enjoys practicing the Wim Hof breathing technique in and out of the lab. While away from the lab, however, he can be found with his wife and son. His hobbies include exercising, playing music on the guitar, practicing Jiu Jitsu, meditating, and hiking/camping.